Merck: veterinary product receives go-ahead from EU

(CercleFinance.com) - Merck's animal health unit said that a European Medicines Agency (EMA) panel has recommended a spot-on solution for cats, with a view to European Commission approval later this year.


The Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion recommending marketing authorization for Bravecto Plus for cats with parasite infestations.

Once applied, Bravecto Plus provides tick and flea killing activity for 12 weeks, prevents heartworm disease for 8 weeks, and also treats roundworm and hookworm, Merck said.

Merck also announced the appointment of Jennifer Zachary as general counsel, with responsibility for legal, security, and environmental, health and safety organizations.

Copyright (c) 2018 CercleFinance.com. All rights reserved.